Article Details
Retrieved on: 2018-01-08 01:28:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Generation Bio: $25 million from <b>Atlas Venture</b> to develop titratable gene therapies that can be redosed over the life of the patient. The biotech firm is founded on technology from the labs of former National Institutes of Health scientist Robert Kotin, who discovered close-ended DNA—a nonviral way of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here